- Home
- TNGX vs FOF Comparison
TNGX vs FOF Comparison
Compare TNGX & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- FOF
- Stock Information
- Founded
- TNGX 2014
- FOF 2006
- Country
- TNGX United States
- FOF United States
- Employees
- TNGX N/A
- FOF N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- TNGX Health Care
- FOF Finance
- Exchange
- TNGX Nasdaq
- FOF Nasdaq
- Market Cap
- TNGX 317.4M
- FOF 341.7M
- IPO Year
- TNGX N/A
- FOF N/A
- Fundamental
- Price
- TNGX $1.28
- FOF $12.15
- Analyst Decision
- TNGX Strong Buy
- FOF
- Analyst Count
- TNGX 7
- FOF 0
- Target Price
- TNGX $12.33
- FOF N/A
- AVG Volume (30 Days)
- TNGX 789.6K
- FOF 58.7K
- Earning Date
- TNGX 05-07-2025
- FOF 01-01-0001
- Dividend Yield
- TNGX N/A
- FOF 9.07%
- EPS Growth
- TNGX N/A
- FOF N/A
- EPS
- TNGX N/A
- FOF N/A
- Revenue
- TNGX $42,069,000.00
- FOF N/A
- Revenue This Year
- TNGX N/A
- FOF N/A
- Revenue Next Year
- TNGX N/A
- FOF N/A
- P/E Ratio
- TNGX N/A
- FOF N/A
- Revenue Growth
- TNGX 15.17
- FOF N/A
- 52 Week Low
- TNGX $1.24
- FOF $9.59
- 52 Week High
- TNGX $12.02
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- TNGX 24.31
- FOF 48.02
- Support Level
- TNGX $1.48
- FOF $12.00
- Resistance Level
- TNGX $1.66
- FOF $12.29
- Average True Range (ATR)
- TNGX 0.16
- FOF 0.16
- MACD
- TNGX -0.02
- FOF 0.03
- Stochastic Oscillator
- TNGX 5.00
- FOF 71.09
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.